Filing Details

Accession Number:
0000899243-20-034688
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-21 16:05:07
Reporting Period:
2020-12-18
Accepted Time:
2020-12-21 16:05:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214133 H Richard Scheller C/O Bridgebio Pharma, Inc.
421 Kipling Street
Palo Alto CA 94301
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-18 27,105 $64.99 109,156 No 4 S Direct
Common Stock Disposition 2020-12-18 2,895 $65.78 106,261 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the weighted average sale price of the shares sold from $64.67 to $65.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securuity holder of the Issuer, full information regarding the number of share sold at each separate price for all transactions as reported in footnotes 1 and 2.
  2. Represents the weighted average sale price of the shares sold from $65.685 to $65.95 per share.